Nicotine Addiction Clinical Trials

9 recruiting

Nicotine Addiction Trials at a Glance

8 actively recruiting trials for nicotine addiction are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Nicosia, Fehring, and Graz. Lead sponsors running nicotine addiction studies include University of Cyprus, Sigmund Freud PrivatUniversitat, and National Institute of Respiratory Diseases, Mexico.

Browse nicotine addiction trials by phase

Treatments under study

About Nicotine Addiction Clinical Trials

Looking for clinical trials for Nicotine Addiction? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Nicotine Addiction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Nicotine Addiction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community

Substance Use Disorder (SUD)Alcohol Use Disorder (AUD)Nicotine Addiction
Sigmund Freud PrivatUniversitat100 enrolled3 locationsNCT06803706
Recruiting
Early Phase 1

Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder

Nicotine AddictionCraving
University of California, San Diego200 enrolled1 locationNCT06582888
Recruiting
Not Applicable

Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches

Nicotine Addiction
Emory University84 enrolled1 locationNCT07165808
Recruiting
Not Applicable

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

Smoking CessationSchizophreniaNicotine Addiction
The University of Texas Health Science Center, Houston50 enrolled1 locationNCT05276050
Recruiting
Not Applicable

CONNECT Cancer Survivors With Tobacco Treatment

Smoking CessationTobacco Use CessationTobacco Smoking+2 more
Washington University School of Medicine5,000 enrolled1 locationNCT07020273
Recruiting

Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies

Smoking CessationEpigeneticsNicotine Addiction+3 more
University of Cyprus200 enrolled1 locationNCT06471387
Recruiting
Not Applicable

Biopsychosocial Predictors of Nicotine Relapse

SmokingSmoking CessationNicotine Addiction+1 more
University of Cyprus200 enrolled1 locationNCT06470321
Recruiting
Phase 4

Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects

Tobacco SmokingNicotine AddictionNicotine Withdrawal+2 more
National Institute of Respiratory Diseases, Mexico134 enrolled1 locationNCT06254001